Multiple aseptic cellulitis following continuous subcutaneous injection of foslevodopa-foscarbidopa: Two case reports

Lignende værker

• Foslevodopa–Foscarbidopa subcutaneous infusion in Parkinson’s disease: a cross-cultural/cross-racial international multicentre comparative tolerability study (CRIM-FOS study)
  af: Vinod Metta, et al.
  Udgivet: (2026-04-01)
• Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease
  af: K. Ray Chaudhuri, et al.
  Udgivet: (2025-01-01)
• Opicapone as Add-On Therapy to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: Clinical Improvement and Wearable Sensor-Based Gait Analysis
  af: Paolo Solla, et al.
  Udgivet: (2026-05-01)
• Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel
  af: John P. Savaryn, et al.
  Udgivet: (2024-04-01)
• A patient with Parkinson’s disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/foscarbidopa infusion
  af: Hirotaka Sakuramoto, et al.
  Udgivet: (2024-01-01)